Xencor
IPODesigning Proteins Delivering Medicines™
Public · Pasadena, United States · Founded 1997 · $75.1M raised
- Headquarters
- Pasadena, California
- Employees
- 201–500
- Founded
- 1997
- Business Model
- B2B
- Website
- xencor.com
- Total Funding
- $75.1M
- Last Round
- $10.0M Series AJun 2013
- Rounds
- 5
- Type
- Public
About
Clinical-stage biopharmaceutical company developing XmAb-engineered antibodies and cytokines to treat cancer and autoimmune diseases.
Summary
Xencor is a Biotech company based in Pasadena, United States, founded in 1997. It has raised $75.1M in total across 5 rounds, most recently a $10.0M Series A round in Jun 2013. Investors include Moore Capital and Stafford Capital Partners.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2013
Sign up to see all 6 rounds
Venture Round through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/xencor"><img src="https://indexed.vc/api/badge/company/xencor" alt="Xencor on Indexed.vc" width="260" height="76" /></a>